Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Redalpine Summit Fund is an evergreen, multi-stage venture capital fund based in Switzerland that focuses on the continuum of software and science. Launched in 2020, it is designed as a semi-liquid investment vehicle that provides exposure to high-growth European startups from seed to pre-IPO stages. The fund specifically targets disruptive innovations in sectors such as biotechnology, healthcare technology, artificial intelligence, and deeptech. By combining investments in Redalpine's early-stage flagship funds with direct follow-on investments in later-stage 'portfolio superstars,' the Summit Fund aims to support European tech champions throughout their entire lifecycle. Its portfolio includes notable companies in the life sciences and technology sectors, reflecting a team composed largely of scientists and seasoned operators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Summit Fund.